Appointments at Stabilitech, Unilife, Genocea and Amarin – People on the move

By Nick Taylor

- Last updated on GMT

Related tags Chief operating officer Vice president Management occupations

in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Stabilitech, Unilife, Genocea and Amarin.

Biologics stabilisation business Stabilitech​ has appointed Donna Hackett​ as commercial director. Hackett has 20 years of pharma experience working at ProPharma Partners and BTG.

Ramin Mojdeh​ has joined Unilife​ as executive vice president (EVP) and chief operating officer. Mojdeh has 25 years of business leadership from working at Becton Dickinson, GE Healthcare and Boston Scientific.

Genocea Biosciences​ has promoted Chip Clark​ to president and CEO. Clark joined Genocea in August 2010 as chief business officer after previously working at Vanda Pharmaceuticals and SmithKline Beecham.

Paul Huff​ has been named as chief commercial officer at Amarin​. Huff has experience of cardiovascular treatments from time working at Reliant Pharmaceuticals and Kos Pharmaceuticals.

Somaxon Pharmaceuticals ​has hired Robert Cutler​ as VP, business development. Cutler worked at Biogen Idec for eight years after joining the company from a private legal practice.

Angelos Stergiou​ has joined Anavex Life Sciences​ as VP, clinical development and medical affairs. Stergiou has worked with Anavex during his time at Genesis BioPharma.

Aesica ​has appointed a team to manage its European operations after it acquired three sites from UCB. Simon Clough​, who has been at Aesica for three years, is now managing director, formulated products business unit. Katy Linekar​ has also joined the unit as finance director.

Clough and Linekar will be based at the former-UCB site in Monheim, Germany. Helen Taylor ​will relocate to the site for three months as part of integration efforts. Similarly, Edd Wood​ and Janette Waterhouse​ will temporarily work at Pianezza, Italy and Zwickau, Germany respectively.

Related topics Markets & Regulations

Related news

Show more

Follow us


View more